Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Alex Vaskevitch and Zenith High Yield Bond Fund Move to Serone Capital

Monday, January 30, 2012
Opalesque Industry Update - Serone Capital Management announces the appointment of Alex Vaskevitch as a Partner and the addition of the Zenith High Yield Bond Fund onto its platform. Alex will be primarily responsible for managing the firm’s liquid investments, building up the high yield research and execution team.

The Zenith fund focuses on investment opportunities in the European high yield corporate bond market, allocating to both sub-investment grade and stressed debt instruments. The investment process is based on a credit intensive, fundamental, bottom-up approach with a particular emphasis on the risk/reward ratio of each position and the management of the liquidity of the portfolio through nimbleness and efficient position sizing.

The fund will continue to be managed by Alex Vaskevitch, whom since taking over as fund manager in October 2008 has delivered to investors net returns in excess of 70%.

Alex will be fully integrated within Serone’s existing investment team. The combination of his high yield expertise with the Serone team’s credit experience will create numerous synergies and will prove beneficial to the fund’s investors. Alex’s focus on liquid credit investments is very complementary to Serone’s existing product offering of structured credit and distressed/NPL portfolios.

Serone believes that credit currently offers a very attractive risk/return profile compared to other asset classes, and is committed to offering its investors high quality asset management capabilities across the entire credit spectrum. Serone believes that European credit markets, and corporate high yield in particular are dislocated and sees tremendous investment opportunities in both the short and long term.

(press release)

Serone Capital Management LLP (“Serone”) is an asset management and advisory firm with a focus on European credit opportunities. Serone is authorised and regulated by the FSA since 2010. www.seronecapital.com


See our 2009 coverage of the Zenith High Yield Bond fund:
Opalesque Exclusive: LNG's credit fund up 32.4% YTD, managers believe high yield bonds will continue to be attractive asset class over medium and long-run Source

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und